Implications of ethnicity among patients with metastatic renal cell carcinoma (mRCC) treated with nivolumab plus ipilimumab (nivo/ipi).

被引：0
|
作者：
Leong, Sally
Ali, Sana
Zengin, Zeynep Busra
Meza, Luis A.
Dizman, Nazli
Ebrahimi, Hedyeh
Govindarajan, Ameish
Castro, Daniela V.
Li, Xiaochen
Kim, Tane
Melamed, Sam
Pal, Sumanta Monty
Chehrazi-Raffle, Alex
机构：
[1] Harbor UCLA Med Ctr, Torrance, CA USA
[2] City Hope Comprehens Canc Ctr, Duarte, CA USA
[3] Lundquist Res Inst, Torrance, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
613
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Three Cases of Nivolumab Plus Ipilimumab Therapy in Haemodialysis Patients With Metastatic Renal Cell Carcinoma
    Kobari, Yuki
    Yoshida, Kazuhiko
    Iizuka, Junpei
    Kondo, Tsunenori
    Ishida, Hideki
    Tanabe, Kazunari
    Takagi, Toshio
    IN VIVO, 2021, 35 (06): : 3585 - 3589
  • [42] Body composition in patients with metastatic renal cell carcinoma receiving ipilimumab plus nivolumab.
    Dzimitrowicz, Hannah Elizabeth
    Schwartz, Fides
    Infield, Jordan
    Zhang, Dylan
    Ho, Ethan
    Wu, Yuan
    Gupta, Rajan T.
    Harrison, Michael Roger
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16517 - E16517
  • [43] The safety and early efficacy of high-dose ipilimumab (IPI) and the combination nivolumab plus ipilimumab (NIVO plus IPI) in patients (pts) with uveal melanoma (UM).
    Patel, Sapna Pradyuman
    Glitza, Isabella Claudia
    Diab, Adi
    Amaria, Rodabe Navroze
    Davies, Michael A.
    Hwu, Patrick
    Tawbi, Hussein Abdul-Hassan
    Hwu, Wen-Jen
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [44] Longitudinal multiplex cytokine analysis for patients (pts) with metastatic renalcell carcinoma (mRCC) treated with ipilimumab/nivolumab (I plus N).
    Zhang, Tian
    Wu, Yuan
    Agarwal, Anika
    Starr, Mark D.
    Reyes-Martinez, Marco
    Anand, Monika
    Runyambo, Daniella
    Harrison, Michael Roger
    Armstrong, Andrew J.
    George, Daniel J.
    Nixon, Andrew B.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [45] Nivolumab (NIVO) plus /- relatlimab (RELA) or ipilimumab (IPI) for patients (pts) with advanced treatment-naive or -refractory basal cell carcinoma (BCC)
    Schenk, K. M.
    Deutsch, J. S.
    Schollenberger, M. D.
    Sharfman, W. H.
    Brothers, P. N.
    Pons, A.
    Scott, J. F.
    Bibee, K.
    Taube, J. M.
    Topalian, S. L.
    Lipson, E. J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S922 - S923
  • [46] Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab
    Brown, Landon C.
    Desai, Kunal
    Wei, Wei
    Kinsey, Emily N.
    Kao, Chester
    George, Daniel J.
    Rini, Brian, I
    Ornstein, Moshe C.
    Zhang, Tian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (09)
  • [47] Clinical outcomes in metastatic renal cell carcinoma (mRCC) treated with combination of nivolumab and cabozantinib (nivo-cabo) in the salvage setting.
    Ravindranathan, Deepak
    Liu, Yuan
    Martini, Dylan J.
    Nazha, Bassel
    Brown, Jacqueline T.
    Russler, Greta
    Yantorni, Lauren Beth
    Caulfield, Sarah
    Master, Viraj A.
    Carthon, Bradley Curtis
    Kucuk, Omer
    Bilen, Mehmet Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [48] Phase I/IB trial of sitravatinib (Sitra) plus nivolumab (Nivo) plus ipilimumab (Ipi) in patients (pts) with advanced clear cell renal cell carcinoma (accRCC) or other solid malignancies.
    Msaouel, Pavlos
    Gao, Jianjun
    Yuan, Ying
    Siefker-Radtke, Arlene O.
    Jonasch, Eric
    Goswami, Sangeeta
    Zurita, Amado J.
    Campbell, Matthew T.
    Shah, Amishi Yogesh
    Corn, Paul G.
    Ramos, Claudia
    Yan, Xiaohong
    Chin, Curtis
    Der-Torossian, Hirak
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [49] Impact of β-blockers (BB) on outcomes of metastatic renal cell carcinoma (mRCC) patients treated with nivolumab (N)
    Silva, C. Alves Costa
    Derosa, L.
    Dalban, C.
    Colomba, E.
    Negrier, S.
    Chevreau, C. M.
    Gravis, G.
    Oudard, S. M.
    Laguerre, B.
    Barthelemy, P.
    Borchiellini, D.
    Gross-Goupil, M.
    Geoffrois, L.
    Rolland, F.
    Thiery-Vuillemin, A.
    Joly, F.
    Ladoire, S.
    Tantot, F.
    Escudier, B.
    Albiges, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S710 - S710
  • [50] Real-world outcomes in patients with metastatic renal cell carcinoma treated with first-line nivolumab plus ipilimumab
    Doshi, Gurjyot K.
    Robert, Nicholas J.
    Chen, Liwei
    Chan, Philip K.
    Del Tejo, Viviana
    Stwalley, Brian
    Huo, Stephen
    Geynisman, Daniel M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
12345